Defect in lipoprotein lipase enzyme leads to
So, if there's a defect in LPL, the enzyme can't do its job. Triglycerides in chylomicrons and very low-density lipoproteins (VLDL) wouldn't be hydrolyzed. This would lead to an accumulation of these particles in the blood. The main consequence would be hypertriglyceridemia, right? Because the body can't process the triglycerides effectively.
Now, what are the clinical conditions associated with high triglycerides? I think familial lipoprotein lipase deficiency is a rare genetic disorder that causes this. Patients might present with eruptive xanthomas, abdominal pain from pancreatitis, and milky plasma due to the chylomicrons.
Looking at the options, the correct answer should be hypertriglyceridemia or a related condition. Let's check the options again. The options are A to D, but the user didn't list them. However, the correct answer is probably hypertriglyceridemia. Let me confirm: LPL is crucial for breaking down chylomicrons and VLDL. Without it, triglycerides stay in the blood, leading to elevated levels. So the defect leads to hypertriglyceridemia.
Now, why are the other options wrong? If there are options like hypercholesterolemia, that's incorrect because that's more related to issues with LDL. Hypolipidemia is the opposite, so that's wrong. Maybe another option is about a specific type of xanthoma, but that's a symptom, not the primary defect. Also, if there's an option about low HDL, that's not directly caused by LPL deficiency.
Clinical pearls: LPL deficiency causes type I hyperlipoproteinemia, characterized by chylomicronemia. It's important to remember that LPL is necessary for the metabolism of triglyceride-rich lipoproteins. Patients might present with acute pancreatitis due to the high triglyceride levels, which is a common exam question point.
So putting it all together, the core concept is the role of LPL in triglyceride metabolism. The correct answer is hypertriglyceridemia. The wrong options are other lipid disorders that don't result from LPL defects. The clinical pearl is the link between LPL deficiency and type I hyperlipoproteinemia with chylomicronemia.
**Core Concept**
Lipoprotein lipase (LPL) is a key enzyme in triglyceride metabolism, located on capillary endothelium. It hydrolyzes triglycerides in chylomicrons and very low-density lipoproteins (VLDL), releasing free fatty acids for tissue use. Defects in LPL activity lead to impaired lipid clearance, causing hypertriglyceridemia.
**Why the Correct Answer is Right**
A defect in LPL prevents the hydrolysis of triglycerides in chylomicrons and VLDL,